Two markers complement each other in identifying risk.
Ruth
R
SoRelle
D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase; D019386:Alendronate / Q000627:therapeutic use*; D015415:Biomarkers; D002097:C-Reactive Protein / Q000032:analysis*; D002117:Calcitriol / Q000627:therapeutic use; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000097:blood* / Q000453:epidemiology; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D007674:Kidney Diseases / Q000453:epidemiology*; D008297:Male; D010024:Osteoporosis / Q000517:prevention & control*; D010741:Phospholipases A / Q000097:blood*; D011183:Postoperative Complications / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D012306:Risk
D015415:Biomarkers; D008078:Cholesterol, LDL; D002097:C-Reactive Protein; D010741:Phospholipases A; D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase; D002117:Calcitriol; D019386:Alendronate